Rigel Pharmaceuticals, Inc.
RIGL
$45.92
$1.513.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 124.41% | 120.72% | 55.60% | 35.81% | -1.98% |
| Total Receivables | 50.20% | 38.07% | 51.01% | 36.22% | 29.85% |
| Inventory | 151.85% | 54.27% | 125.15% | 77.51% | 33.90% |
| Prepaid Expenses | -18.33% | -9.55% | -36.75% | 1.66% | 118.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 101.87% | 85.16% | 58.47% | 36.10% | 12.04% |
|
|
|||||
| Total Current Assets | 101.87% | 85.16% | 58.47% | 36.10% | 12.04% |
| Net Property, Plant & Equipment | 119.05% | 82.96% | 62.09% | -67.06% | -57.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.49% | -8.31% | -8.15% | 95.27% | 95.72% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -75.49% | -11.64% | -64.89% | -53.03% | -3.93% |
| Total Assets | 73.96% | 61.00% | 39.09% | 39.88% | 20.89% |
|
|
|||||
| Total Accounts Payable | 0.81% | 18.92% | -57.37% | -53.25% | -52.31% |
| Total Accrued Expenses | 12.15% | 45.03% | 55.39% | 58.24% | 47.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6,413.95% | 3,480.28% | -7.40% | -34.64% | -91.53% |
| Total Finance Division Other Current Liabilities | 76.48% | -45.56% | -71.71% | 14.98% | 24.56% |
| Total Other Current Liabilities | 76.48% | -45.56% | -71.71% | 14.98% | 24.56% |
| Total Current Liabilities | 73.81% | 47.72% | -8.97% | 18.83% | 12.51% |
|
|
|||||
| Total Current Liabilities | 73.81% | 47.72% | -8.97% | 18.83% | 12.51% |
| Long-Term Debt | -69.95% | -62.43% | 0.02% | 0.08% | 1.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 764.00% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -18.91% | -21.17% | -0.50% | 10.16% | 4.69% |
|
|
|||||
| Common Stock & APIC | 1.36% | 1.01% | 0.94% | 1.05% | 0.97% |
| Retained Earnings | 8.07% | 6.90% | 2.63% | 1.24% | 0.28% |
| Treasury Stock & Other | 772.73% | 166.67% | 60.00% | 25.00% | 173.33% |
| Total Common Equity | 903.56% | 373.90% | 158.62% | 111.48% | 54.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 903.56% | 373.90% | 158.62% | 111.48% | 54.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 903.56% | 373.90% | 158.62% | 111.48% | 54.02% |
|
|
|||||